AKT1 and triple-negative breast carcinoma: Overall, our results clearly indicate that TMEPAI promotes PTEN loss through increased PTEN turnover (Figs. 5 and 6), which probably enhances non-canonical PI3K/Akt activity in triple negative breast cancer cells in response to TGF-β.